Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
3 drugs in development
By Therapeutic Area
top 6
R&D Momentum
54/100
Pipeline Velocity
19/100
Trial Completion Rate
100/100
Pipeline Concentration
14/100
Pipeline Freshness
50/100
Strategic Signals
Activity
Last 14 days
Effectiveness of an Integrated Video Modelling and Spherical Video-Based Virtual Reality Intervention for Social Communication in Autistic Young Adults: A Randomized Controlled Trial
Comparative Analysis of Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection (ALTON-PI)
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)